Express News | Alnylam Announces Retirement of Longtime Board Member, DR. Phillip a. Sharp, Company Co-Founder and Industry Luminary

ReutersMar 5 07:00 ET

Alnylam Announces Retirement of Longtime Board Member, Dr. Phillip A. Sharp, Company Co-Founder and Industry Luminary

Alnylam Pharmaceuticals, Inc.Mar 5 00:00 ET

CCORF Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $385

Moomoo NewsFeb 27 07:31 ET · Ratings

Alnylam Pharmaceuticals: Balancing Promising Pipeline With Competitive Challenges and Strategic Uncertainties

TipRanksFeb 27 04:37 ET

Here's How Much You Would Have Made Owning Alnylam Pharmaceuticals Stock In The Last 20 Years

BenzingaFeb 26 15:00 ET

BMO Capital Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $300

Moomoo NewsFeb 26 08:31 ET · Ratings